SCHEMBL413509

SCHEMBL413509

Cc1cccc(-c2nn3cc(C(=O)NCCN(C)C)ccc3c2-c2ccc(F)cc2)n1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 3/20 0.47
CDC7 O00311 1/20 0.42
CDK19 Q9BWU1 1/20 0.42
RAD52 P43351 1/20 0.41
HPGD P15428 1/20 0.41
THRB P10828 1/20 0.41
PARP1 P09874 1/20 0.39
PKM P14618 1/20 0.39
FYN P06241 6/20 0.39
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
CCNT1 O60563 1/20 0.38
CCNE1 P24864 1/20 0.38
CDK2 P24941 1/20 0.38
CDK9 P50750 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5234295 0.86 TGFBR1 (0.39) TGFBR1RAD52THRB
SCHEMBL4873313 0.82 TGFBR1 (0.51) TGFBR1THRB
SCHEMBL4865446 0.80 TGFBR1 (0.53) TGFBR1HPGDTHRB
SCHEMBL414625 0.76 TGFBR1 (0.49) TGFBR1THRB
SCHEMBL4874607 0.74 TGFBR1 (0.52) TGFBR1THRB
SCHEMBL455896 0.74 CYP2D6 (0.41) TGFBR1HPGD
SCHEMBL4869716 0.73 PTGS2 (0.53) TGFBR1THRB
SCHEMBL412300 0.71 TGFBR1 (0.70) TGFBR1
SCHEMBL412319 0.71 TGFBR1 (0.61) TGFBR1THRB
SCHEMBL4868119 0.71 MAPK14 (0.60) TGFBR1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120021519-A1 EFFICIENT INDUCTION OF PLURIPOTENT STEM CELLS USING SMALL MOLECULE COMPOUNDS PRESIDENTS AND FELLOWS OF HARVARD COLLEGE (US) 2012-01-26 US disclosed
US-7365066-B2 Pyrazolopyridine derivatives as pharmaceutical agents ELI LILLY AND COMPANY (US) 2008-04-29 US disclosed
US-7365066-B2 Pyrazolopyridine derivatives as pharmaceutical agents ELI LILLY AND COMPANY (US) 2008-04-29 US disclosed